41 related articles for article (PubMed ID: 38630470)
1. Relationship between residual visual field and full-field stimulus testing in patients with late-stage retinal degenerative diseases.
Sakai D; Maeda T; Yamamoto M; Yokota S; Maeda A; Hirami Y; Nakamura M; Kurimoto Y; Mandai M
Sci Rep; 2024 Feb; 14(1):2793. PubMed ID: 38307956
[TBL] [Abstract][Full Text] [Related]
2. Progression Rate of Visual Function and Affecting Factors at Different Stages of Retinitis Pigmentosa.
Ito N; Miura G; Shiko Y; Kawasaki Y; Baba T; Yamamoto S
Biomed Res Int; 2022; 2022():7204954. PubMed ID: 35872870
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Full-Field Stimulus Threshold Measurements in Patients With Retinitis Pigmentosa and Healthy Subjects With Dilated and Nondilated Pupil.
Reith M; Stingl K; Kühlewein L; Kempf M; Stingl K; Langrova H
Transl Vis Sci Technol; 2024 Apr; 13(4):23. PubMed ID: 38630470
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Full-Field Stimulus Threshold Test Results in Retinitis Pigmentosa: Relationship with Full-Field Electroretinography, Multifocal Electroretinography, Optical Coherence Tomography, and Visual Field.
Öner A; Kahraman NS
Turk J Ophthalmol; 2024 Feb; 54(1):23-31. PubMed ID: 38385317
[TBL] [Abstract][Full Text] [Related]
5. Psychophysically determined full-field stimulus thresholds (FST) in retinitis pigmentosa: relationships with electroretinography and visual field outcomes.
Messias K; Jägle H; Saran R; Ruppert AD; Siqueira R; Jorge R; Messias A
Doc Ophthalmol; 2013 Oct; 127(2):123-9. PubMed ID: 23733195
[TBL] [Abstract][Full Text] [Related]
6. Chromatic Full-Field Stimulus Threshold and Pupillography as Functional Markers for Late-Stage, Early-Onset Retinitis Pigmentosa Caused by
Stingl KT; Kuehlewein L; Weisschuh N; Biskup S; Cremers FPM; Khan MI; Kelbsch C; Peters T; Ueffing M; Wilhelm B; Zrenner E; Stingl K
Transl Vis Sci Technol; 2019 Nov; 8(6):45. PubMed ID: 31879567
[TBL] [Abstract][Full Text] [Related]
7. Full-field sensitivity threshold and the relation to the oxygen metabolic retinal function in retinitis pigmentosa.
Zabek O; Calzetti G; Prétot D; Scholl HPN; Della Volpe Waizel M
Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2517-2527. PubMed ID: 35355116
[TBL] [Abstract][Full Text] [Related]
8. Analysis of retinal function using chromatic pupillography in retinitis pigmentosa and the relationship to electrically evoked phosphene thresholds.
Kelbsch C; Maeda F; Lisowska J; Lisowski L; Strasser T; Stingl K; Wilhelm B; Wilhelm H; Peters T
Acta Ophthalmol; 2017 Jun; 95(4):e261-e269. PubMed ID: 27683070
[TBL] [Abstract][Full Text] [Related]
9. Full-field stimulus threshold testing: a scoping review of current practice.
Shi LF; Hall AJ; Thompson DA
Eye (Lond); 2024 Jan; 38(1):33-53. PubMed ID: 37443335
[TBL] [Abstract][Full Text] [Related]
10. Therapy with voretigene neparvovec. How to measure success?
Stingl K; Kempf M; Jung R; Kortüm F; Righetti G; Reith M; Dimopoulos S; Ott S; Kohl S; Stingl K
Prog Retin Eye Res; 2023 Jan; 92():101115. PubMed ID: 36096933
[TBL] [Abstract][Full Text] [Related]
11. Correlations of Full-Field Stimulus Threshold With Functional and Anatomical Outcome Measurements in Advanced Retinitis Pigmentosa.
Ngo WK; Jenny LA; Kim AH; Kolesnikova M; Greenstein VC; Tsang SH
Am J Ophthalmol; 2023 Jan; 245():155-163. PubMed ID: 35870488
[TBL] [Abstract][Full Text] [Related]
12. Chromatic Full-Field Stimulus Thresholds in Patients with Treatment-Naive Age-Related Macular Degeneration.
William A; Dias Blak M; Eshref A; Gekeler F; Schatz A; Gekeler K
Clin Ophthalmol; 2022; 16():223-229. PubMed ID: 35125864
[TBL] [Abstract][Full Text] [Related]
13. Full-field stimulus testing: Role in the clinic and as an outcome measure in clinical trials of severe childhood retinal disease.
Roman AJ; Cideciyan AV; Wu V; Garafalo AV; Jacobson SG
Prog Retin Eye Res; 2022 Mar; 87():101000. PubMed ID: 34464742
[TBL] [Abstract][Full Text] [Related]
14. Safety and improved efficacy signals following gene therapy in childhood blindness caused by
Jacobson SG; Cideciyan AV; Ho AC; Peshenko IV; Garafalo AV; Roman AJ; Sumaroka A; Wu V; Krishnan AK; Sheplock R; Boye SL; Dizhoor AM; Boye SE
iScience; 2021 May; 24(5):102409. PubMed ID: 33997691
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
